Company intelligence / Profile preview
Aligos Therapeutics
South San Francisco, California, United Statesaligos.com ↗
- Ownership
- Public · ALGS
- Employees
- ~70
- Development stage
- Other
01
Overview
Aligos Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule therapies for liver and viral diseases. Its lead programs include ALG‑000184 for chronic hepatitis B virus infection—showing sustained HBV DNA suppression in both HBeAg-positive and negative subjects—and ALG‑055009 for MASH, which demonstrated statistically significant reductions in liver fat with favorable safety/tolerability in the Phase 2a HERALD study. The company also has an oral protease inhibitor program targeting COVID‑19. Recent data presentations at major conferences have highlighted robust efficacy signals across its pipeline.
- Therapeutic areas
- Metabolic DisordersInfectious Diseases
- Modalities
- Small molecules (e.g., capsid assembly modulators, THR-beta agonists)
- Industry
- Biotech
02
Drug pipeline
36 assets35 more assets in the full pipeline.
03
Partnerships
Xiamen Amoytop Biotech Co., Ltd. — funding exploratory clinical study of ALG‑000184 + PEGBING® + entecavir combination therapy for HBV in ChinaAGILE University of Liverpool — sponsoring trial of ALG–097558 for COVID–19 under UK government supportNIAID — supporting PK/drug-drug interaction studies with ALG–097558
04
Financials
- Market cap
- $28.2M
- Total revenue
- $2.2M
- Enterprise value
- $1.3M
Beyond the preview
Go deeper on Aligos Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aligos Therapeutics.